Meridian Bioscience – VIVO – Awarded New Agreement with Premier Healthcare Alliance
Meridian Bioscience, Inc. (NASDAQ: VIVO) announced it has signed a new group purchasing agreement with the Premier healthcare alliance to offer illumigene(R) C. difficile and illumigene Group B Streptococcus to its members at specially...